Multimedia
Watch: Cipla on Covid and beyond
The unforeseen nature and the extent of the pandemic has irrevocably changed the pharmaceutical industry. Amidst a global healthcare crisis, pharmaceutical behemoths across the world rushed to find a vaccine to curb the spread of the contagion.
Watch Umang Vohra, global MD & CEO, Cipla, talk about the pandemic expediting a paradigm shift in the pharma industry—one from "illness" to "wellness"; Cipla's plans of the booster shots of the Covid-19 vaccines, and the future of the pharma industry beyond the pandemic.
Also Read
-
Tata Technologies FY24 profit surges 9% at ₹679 cr; revenue grows 16%
-
WhatsApp India bans 2.2 crore accounts in Jan-March
-
Titan Q4 profit rises 5% to ₹771 crore
-
Adani Green Q4 profit drops 39% to ₹310 cr
-
Godrej Properties Q4 profit up 14%; revenue down 13% to ₹1,426 cr